CDKN2A and hepatocellular carcinoma: Eventually, 10 potential TAA targets were investigated from 75 HCC driver genes, including p16, SETDB1, RNA helicase A, BRG1, GNAS, Merlin, DNMT3A, NRAS, GMPS, and ERK2 (Table 2).